发明名称 Piperazine compounds as inhibitors of MMP or TNF
摘要 A compound of formula (I) wherein A is a sulfonyl or a carbonyl; R1 is an optionally substituted aryl, an optionally substituted heterocyclic group, an optionally substituted lower alkyl or an optionally substituted lower alkenyl; R2 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; R3 is an optionally substituted lower alkyl, an optionally substituted lower alkoxy, an optionally substituted aryloxy, an optionally substituted lower alkenyl, an optionally substituted aryl, an optionally substituted heterocyclic group or an optionally substituted amino; R4 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; R5 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; and R10 is a hydroxy or a protected hydroxy, and a pharmaceutically acceptable salt thereof. The compound of the present invention is useful as a medicament for prophylactic and therapeutic treatment of MMP-or TNFalpha-medicated diseases.
申请公布号 US2003060473(A1) 申请公布日期 2003.03.27
申请号 US20020262841 申请日期 2002.10.03
申请人 FUJISAWA PHARMACEUTICAL CO., LTD. 发明人 NEYA MASAHIRO;YAMAZAKI HITOSHI;KAYAKIRI NATSUKO;SATO KENTARO;OKU TERUO
分类号 A61K31/495;A61K31/496;A61P17/02;A61P17/06;A61P19/02;A61P43/00;C07D241/04;C07D405/12;C07D405/14;C07D407/12;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14;(IPC1-7):A61K31/496;C0743/02 主分类号 A61K31/495
代理机构 代理人
主权项
地址